The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Disulfide-Based Multifunctional Conjugates for Targeted Theranostic Drug Delivery
Abstract
Theranostics, chemical entities designed to combine therapeutic effects and imaging capability within one molecular system, have received considerable attention in recent years. Much of this interest reflects the promise inherent in personalized medicine, including disease-targeted treatments for cancer patients. One important approach to realizing this latter promise involves the development of so-called theranostic conjugates, multicomponent constructs that selectively target cancer cells and deliver cytotoxic agents while producing a readily detectable signal that can be monitored both in vitro and in vivo. This requires the synthesis of relatively complex systems comprising imaging reporters, masked chemotherapeutic drugs, cleavable linkers, and cancer targeting ligands. Ideally, the cleavage process should take place within or near cancer cells and be activated by cellular components that are associated with cancer states or specifically expressed at a higher level in cancer cells. Among the cleavable linkers currently being explored for the construction of such localizing conjugates, disulfide bonds are particularly attractive. This is because disulfide bonds are stable in most blood pools but are efficiently cleaved by cellular thiols, including glutathione (GSH) and thioredoxin (Trx), which are generally found at elevated levels in tumors. When disulfide bonds are linked to fluorophores, changes in emission intensity or shifts in the emission maxima are typically seen upon cleavage as the result of perturbations to internal charge transfer (ICT) processes. In well-designed systems, this allows for facile imaging. In this Account, we summarize our recent studies involving disulfide-based fluorescent drug delivery conjugates, including preliminary tests of their biological utility in vitro and in vivo. To date, a variety of chemotherapeutic agents, such as doxorubicin, gemcitabine, and camptothecin, have been used to create disulfide-based conjugates, as have a number of fluorophores, including naphthalimide, coumarin, BODIPY, rhodol, and Cy7. The resulting theranostic core (drug-disulfide-fluorophore) can be further linked to any of several site-localizing entities, including galactose, folate, biotin, and the RGD (Arg-Gly-Asp) peptide sequence, to create systems with an intrinsic selectivity for cancer cells over normal cells. Site-specific cleavage by endogenous thiols serves to release the cytotoxic drug and produce an easy-to-monitor change in the fluorescence signature of the cell. On the basis of the results summarized in this Account, we propose that disulfide-based cancer-targeting theranostics may have a role to play in advancing drug discovery efforts, as well as improving our understanding of cellular uptake and drug release mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Nature · doi:10.1038/309030a0 · Cited by 3,658
Shedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
A mechanism for gene conversion in fungi
Holliday, R. (1964) · Genetical Research · doi:10.1017/s0016672300001233 · Cited by 1,403
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
Disulfide-Cleavage-Triggered Chemosensors and Their Biological Applications
Lee, M. H., Yang, Z., Lim, C. W., Lee, Y. H., Dongbang, S., Kang, C., & Kim, J. S. (2013) · Chemical Reviews · doi:10.1021/cr300358b · Cited by 821
Self-citationHertzberg, R. P., Caranfa, M. J., & Hecht, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a018 · Cited by 551
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Mucoadhesive nanoparticulate systems for peptide drug delivery
Takeuchi, H., Yamamoto, H., & Kawashima, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00120-4 · Cited by 488
Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takéuchi, Hirofumi, Yamamoto, Y., Hiromitsu, Kawashima, & Yoshiaki (2002) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 432
Lee, M. H., Han, J. H., Kwon, P.-S., Bhuniya, S., Kim, J. Y., Sessler, J. L., Kang, C., & Kim, J. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210065g · Cited by 408
Self-citationVitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
Russell-Jones, G., McTavish, K., McEwan, J., Rice, J., & Nowotnik, D. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.07.009 · Cited by 392
Chen, S., Zhao, X., Chen, J., Chen, J., Kuznetsova, L., Wong, S. S., & Ojima, I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9005656 · Cited by 357
Heo, D. N., Yang, D. H., Moon, H.-J., Lee, J. B., Bae, M. S., Lee, S. C., Lee, W. J., Sun, I.-C., & Kwon, I. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.064 · Cited by 357
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
The Stability of N-Ethylmaleimide and its Reaction with Sulfhydryl Groups
Gregory, J. D. (1955) · Journal of the American Chemical Society · doi:10.1021/ja01619a073 · Cited by 345
Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
Maiti, S., Park, N., Han, J. H., Jeon, H. M., Lee, J. H., Bhuniya, S., Kang, C., & Kim, J. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401350x · Cited by 327
Self-citationLee, M. H., Kim, J. Y., Han, J. H., Bhuniya, S., Sessler, J. L., Kang, C., & Kim, J. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303998y · Cited by 309
Self-citationQuantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang, X., Xiong, Z., Wu, Y., Cai, W., Tseng, J. R., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 282
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Cytotoxic chemotherapy: clinical aspects
Corrie, P. G. (2008) · Medicine · doi:10.1016/j.mpmed.2007.10.012 · Cited by 227
Kato, T., Sato, N., Hayama, S., Yamabuki, T., Ito, T., Miyamoto, M., Kondo, S., Nakamura, Y., & Daigo, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1307 · Cited by 219
An Activatable Theranostic for Targeted Cancer Therapy and Imaging
Bhuniya, S., Maiti, S., Kim, E., Lee, H., Sessler, J. L., Hong, K. S., & Kim, J. S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311133 · Cited by 215
Self-citationFolate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery
Yang, Z., Lee, J. H., Jeon, H. M., Han, J. H., Park, N., He, Y., Lee, H., Hong, K. S., Kang, C., & Kim, J. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405372k · Cited by 212
Self-citationCai, W., Wu, Y., Chen, K., Cao, Q., Tice, D. A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1480 · Cited by 187
Understanding Ribonucleotide Reductase Inactivation by Gemcitabine
Cerqueira, N. M. F. S. A., Fernandes, P. A., & Ramos, M. J. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200700260 · Cited by 161
A fluorescence off–on reporter for real time monitoring of gemcitabine delivery to the cancer cells
Bhuniya, S., Lee, M. H., Jeon, H. M., Han, J. H., Lee, J. H., Park, N., Maiti, S., Kang, C., & Kim, J. S. (2013) · Chemical Communications · doi:10.1039/c3cc42653j · Cited by 91
Self-citationGunderson, C. W., & Segall, A. M. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05009.x · Cited by 61
A biotin-guided fluorescent-peptide drug delivery system for cancer treatment
Kim, T. Y., Jeon, H. M., Le, H. T., Kim, T. W., Kang, C., & Kim, J. S. (2014) · Chemical Communications · doi:10.1039/c4cc02878c · Cited by 59
Self-citationSaksena, S., Shao, Y., Braunagel, S. C., Summers, M. D., & Johnson, A. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404934101 · Cited by 58
Applications for site-directed molecular imaging agents coupled with drug delivery potential
Wang, H., & Chen, X. S. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902889751 · Cited by 31
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Gao, M., Yu, F., Lv, C., Choo, J., & Chen, L. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00908e · Cited by 827
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Li, H., Kim, H., Xu, F., Han, J., Yao, Q., Wang, J., Pu, K., Peng, X., & Yoon, J. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00307k · Cited by 509
Cyclodextrin‐Based Multistimuli‐Responsive Supramolecular Assemblies and Their Biological Functions
Zhang, Y., Liu, Y., & Liu, Y. (2020) · Advanced Materials · doi:10.1002/adma.201806158 · Cited by 400
Metadata
- Authors
- Lee, M. H., Sessler, J. L., & Kim, J. S.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-10-29
- Volume
- 48
- Issue
- 11
- Pages
- 2935-2946
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2267839449
- Cited by
- 254
- References
- 33
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.